Don’t prescribe proton pump inhibitors (PPI) during steroid therapy or for long periods with patients that exhibit dyspeptic symptoms.
There’s no evidence supporting the systematic use of PPI on patients with functional dyspepsia or as prophylaxis during steroid therapy. The primary risk associated with suspending PPI during the course of acid-related disease is the return of symptoms. The...
Don’t repeat esofagogastroduodenoscopy (EGDS) for a patient that has been diagnosed with a gastroesophageal reflux disease, with or without hiatal hernia, in absence of new symptoms.
A diagnosis of gastroesophageal reflux disease is based on a combination of symptoms, feedback from antisecretory drugs, and diagnostic tests; EGDS allows for the diagnosis and eventual treatment of disease related complications; follow-up EGDS is only needed for...
Don’t perform surveillance colonoscopy for colon polyps after a valid exam, with intervals that vary from those indicated by the responsible gastroenterologist or after histologic evaluation of the polyp.
The need for a surveillance colonoscopy should be based on the results of the first endoscopic assessment and is indicated by evidence based guidelines, which evaluate the relative risk of developing new adenomas or carcinomas. The appropriate interval needs to be...
Prescribe fecal occult blood test (FOBT) only for screening of colorectal cancer.
FOBT is a screening test that should only to be used for asymptomatic patients that are in the risky area outlined by the relevant national or regional programs. It’s not a diagnostic test and as such should not be performed for patients that show signs and symptoms...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments